Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa
Inflammatory Intestinal Diseases · 2021 · 6 (2) · 87-100
DOI: 10.1159/000513061 ↗Kurz gefasst
Fachartikel in der Zeitschrift Inflammatory Intestinal Diseases, online erschienen am 29.03.2021. Verfasst von Simona Simmen und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
Introduction
Intestinal fibrosis, characterized by excessive deposition of extracellular matrix proteins, is a common and severe clinical complication of inflammatory bowel disease (IBD). However, the mechanisms underlying fibrosis remain elusive, and currently, there are limited effective pharmacologic treatments that target the development of fibrosis. Hypoxia is one of the key microenvironmental factors influencing intestinal inflammation and has been linked to fibrosis.
Objective
In the present study, we sought to elucidate the impact of hypoxia on fibrotic gene expression in the intestinal mucosa.
Methods
Human volunteers, IBD patients, and dextran sulphate sodium-treated mice were exposed to hypoxia, and colonic biopsies were collected. The human intestinal epithelial cell line Caco-2, human THP-1 macrophages, and primary human gut fibroblasts were subjected to hypoxia, and changes in fibrotic gene expression were assessed.
Results
Human volunteers subjected to hypoxia presented reduced transcriptional levels of fibrotic and epithelial-mesenchymal transition markers in the intestinal mucosa. IBD patients showed a trend towards a decrease in tissue inhibitor of metalloproteinase 1 protein expression. In mice, hypoxic conditions reduced the colonic expression of several collagens and matrix metalloproteinases. Hypoxic Caco-2 cells, THP-1 cells, and primary gut fibroblasts showed a significant downregulation in the expression of fibrotic and tissue remodelling factors.
Conclusions
Stabilization of hypoxia-inducible factors might represent a novel therapeutic approach for the treatment of IBD-associated fibrosis.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Gastroenterology and Hepatology, University of Zurich, Zurich, Switzerland.
- Institute of Physiology, University of Zurich, Zurich, Switzerland.
- Zurich Center for Integrative Human Physiology (ZIHP), University of Zurich, Zurich, Switzerland.
- Center of Gastroenterology, Clinic Hirslanden, Zurich, Switzerland.
Zitieren
APA
Simmen, S., Maane, M., Rogler, S., Baebler, K., Lang, S., Cosin-Roger, J., Atrott, K., Frey-Wagner, I., Spielmann, P., Wenger, R. H., Weder, B., Zeitz, J., Vavricka, S. R., Rogler, G., de Vallière, C., Hausmann, M., & Ruiz, P. A. (2021). Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa. Inflammatory Intestinal Diseases, 6(2), 87-100. https://doi.org/10.1159/000513061
Vancouver
Simmen S, Maane M, Rogler S, Baebler K, Lang S, Cosin-Roger J, et al. Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa. Inflammatory Intestinal Diseases. 2021;6(2):87-100. doi:10.1159/000513061
BibTeX
@article{Simmen2021,
author = {Simmen, Simona and Maane, Max and Rogler, Sarah and Baebler, Katherina and Lang, Silvia and Cosin-Roger, Jesus and Atrott, Kirstin and Frey-Wagner, Isabelle and Spielmann, Partick and Wenger, Roland H and Weder, Bruce and Zeitz, Jonas and Vavricka, Stephan R and Rogler, Gerhard and de Vallière, Cheryl and Hausmann, Martin and Ruiz, Pedro A},
title = {Hypoxia Reduces the Transcription of Fibrotic Markers in the Intestinal Mucosa},
journal = {Inflammatory Intestinal Diseases},
year = {2021},
volume = {6},
number = {2},
pages = {87--100},
doi = {10.1159/000513061}
}
EUVIMED